MeiraGTx Holdings plc
Research MeiraGTx Holdings plc (MGTX) on Bullrun: market cap USD 1.16B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMGTX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 1.16B
- Financial periodFY2025
- RevenueUSD 81.39M
- Revenue growth144.6%
- Net income-USD 114.20M
- Free cash flow-USD 50.19M
Valuation Snapshot
latest market cap is USD 1.16B.
About MeiraGTx Holdings plc
MeiraGTx Holdings plc, a clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative diseases; and xerostomia. It is also develops AAV-AQP1 for radiation-induced grade 2/3 radiation-induced xerostomia, as well as for Sjogren's syndrome; AAV-GAD in Phase 2 trial for Parkinson's disease;
Frequently asked questions
What is MeiraGTx Holdings plc's market cap?
MeiraGTx Holdings plc's market capitalization is USD 1.16B.
What does MeiraGTx Holdings plc do?
MeiraGTx Holdings plc, a clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative diseases;